PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Obstetrics and Gynecology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.\', \'Department of Gastroenterology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey. Electronic address: yavuzbeyazit@comu.edu.tr.\', \'Department of Gastroenterology, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.\', \'Department of Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)32186-110.1016/j.mehy.2020.110150
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32763660
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32763660>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32763660>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all